Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel-Reference-Cited by-同舟云学术

Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel

Published:2018-11 Issue: Volume:278 Page:23-28
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Mangiacapra Fabio^ORCID,Pellicano Mariano,Di Serafino Luigi^ORCID,Bressi Edoardo,Peace Aaron J.,Di Gioia Giuseppe,Morisco Carmine,Bartunek Jozef,Wijns William,Bruyne Bernard De,Barbato Emanuele

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention

2. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding;Tantry;J. Am. Coll. Cardiol.,2013

3. Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention;Mangiacapra;J. Thromb. Haemostasis,2012

4. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention;Braunwald;Clin. Cardiol.,2008

5. Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel;Hamilos;J. Thromb. Thrombolysis,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of ticagrelor and prasugrel on coronary microcirculation in elective percutaneous coronary intervention;Heart;2023-06-14

2. An Examination of Clopidogrel in the Treatment of Coronary Microvascular Disease;Cureus;2022-08-25

3. Sex differences at the platelet–vascular interface;Internal and Emergency Medicine;2022-05-16

4. Oral Antiplatelet Agents in Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06

5. Pathophysiology and mechanisms of Acute Coronary Syndromes: atherothrombosis, immune-inflammation, and beyond;Expert Review of Cardiovascular Therapy;2022-05-04